Evidence map›Paper›PMID 31601700›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

Pharmacokinetic Assessment of

Milan Grkovski, Reema Goel, Simone Krebs, Kevin D Staton, James J Harding, Ingo K Mellinghoff, John L Humm, Mark P S Dunphy

Open access · bronzeAbstract readClinical Trial, Phase I
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. KRAS Mutation Detection with (2Molecular pharmaceutics · 2024
    Article
  6. Review
  7. Article
  8. Metabolic kinetic modeling of [European journal of nuclear medicine and molecular imaging · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Initial evaluation of [EJNMMI research · 2022
    Article
  15. Review
  16. First-in-Human PET Imaging and Estimated Radiation Dosimetry of l-[5-Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  17. [Molecular imaging · 2022
    Article
  18. Kinetic Modeling ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Milan GrkovskiDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Reema GoelDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Simone KrebsDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Kevin D StatonRadiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.
James J HardingDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Ingo K MellinghoffDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
John L HummDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Mark P S DunphyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York dunphym@mkscc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Tumor Evolution and Changes in MetabolismP50CA086438 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI LARSON, STEVEN MARK · 2000 to 2015
$29.9M
MSK Paul Calabresi Career Development Award for Clinical OncologyK12CA184746 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Omar Abdel-Wahab, Simon N. Powell · 2015 to 2026
$8.3M
Molecular Mechanisms of Drug Resistance in Primary Brain TumorsR35NS105109 · NINDS · SLOAN-KETTERING INST CAN RESEARCH · PI MELLINGHOFF, INGO K · 2018 to 2025
$4.7M
Novel PET imaging agents for understanding glutamine addiction in cancerR01CA164490 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHODOSH, LEWIS A, KUNG, HANK F · 2011 to 2015
$4.0M
Biomarkers for predicting response to Hsp90 therapyR01CA172546 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA, DUNPHY, MARK P. · 2013 to 2017
$2.9M
A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of NeuroblastomaR01CA204093 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PANDIT TASKAR, NEETA · 2017 to 2018
$784k
First Human Trial of Src/Abl-Targeted PET Tumor Imaging with F-18 SKI-249380R21CA167803 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI DUNPHY, MARK P. · 2012 to 2013
$736k
NCI NIH HHS K12 CA184746NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA086438NCI NIH HHS R01 CA164490NCI NIH HHS R01 CA172546NCI NIH HHS R01 CA204093NCI NIH HHS R21 CA167803NINDS NIH HHS R35 NS105109
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedFemaleGlutamineHumansMaleMiddle AgedTissue Distribution4-fluoroglutamineGlutaminedynamic PETglutamineglutaminolysiskinetic modelingmetabolism

Identifiers

PMID31601700
PMCPMC7067522
OpenAlexW2979693741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.